A ferroptosis-related signature robustly predicts clinical outcomes and associates with immune microenvironment for thyroid cancer

M Ge, J Niu, P Hu, A Tong, Y Dai, F Xu, F Li - Frontiers in Medicine, 2021 - frontiersin.org
Objective: This study aimed to construct a prognostic ferroptosis-related signature for thyroid
cancer and probe into the association with tumor immune microenvironment. Methods …

How do BRAFV600E and TERT promoter mutations interact with the ATA and TNM staging systems in thyroid cancer?

N Mukhtar, K Alhamoudi, M Alswailem… - Frontiers in …, 2023 - frontiersin.org
Context The American Thyroid Association risk stratification (ATA) and the American Joint
Committee on Cancer Tumor Node Metastases (TNM) predict recurrence and mortality of …

SBP1 promotes tumorigenesis of thyroid cancer through TXN/NIS pathway

J Ma, X Huang, J Xu, Z Li, J Lai, Y Shen, J Zhao… - Molecular …, 2023 - Springer
Background As the tissue with the highest selenium content in the body, the occurrence and
development of thyroid cancer are closely related to selenium and selenoproteins. Selenium …

SEOM-GETNE-TTCC Clinical guideline thyroid cancer (2023)

T Alonso-Gordoa, P Jimenez-Fonseca… - Clinical and …, 2024 - Springer
Abstract Thyroid cancer (TC) represents 3% of global cancer incidence. Recent changes
have optimized treatment decisions based on risk assessment, molecular profiling, and …

Activation of the TGF-β1/Smad signaling by KIF2C contributes to the malignant phenotype of thyroid carcinoma cells

Q Lin, Q Qi, S Hou, Z Chen, N Jiang, L Zhang, C Lin - Tissue and Cell, 2021 - Elsevier
Kinesin family member 2C (KIF2C) has been identified as a potential oncogene in various
types of human cancers; however, the role of KIF2C in thyroid cancer has not yet been …

[HTML][HTML] YAP1 and P53 expression in papillary thyroid carcinoma

DN Abdelhafez, MM Ayoub, SA Mahmoud… - Iranian journal of …, 2023 - ncbi.nlm.nih.gov
Methods: The current study used paraffin blocks of 60 cases of papillary thyroid carcinoma,
which were immunohistochemically assessed for YAP1 and p53 expression. The study …

Dysregulated BCL9 Controls Tumorigenicity and Ferroptosis Susceptibility by Binding With Nrf2 in Thyroid Carcinoma

B Wang, Z Yao, Z Wang, S Yao, X Cen… - Molecular …, 2024 - Wiley Online Library
Thyroid carcinoma (TC) is the most common malignant tumor of the endocrine system with
increasing incidence. In this study, we found that BCL9 is markedly upregulated in human …

LncRNA ATP1A1-AS1 inhibits cell proliferation and promotes cell apoptosis in thyroid carcinoma by regulating the miR-620/IRF2BP2 axis

J Jia, Y Liu, X Yang, Z Wu, X Xu, F Kang… - The American Journal of …, 2023 - Elsevier
Background Thyroid carcinoma (THCA) is a common malignancy of the endocrine system.
Further understanding of the molecular mechanism underlying THCA is crucial to develop …

OPEN ACCESS EDITED BY

A Nicolò, M Lemire, SP Dufour, P Wicker… - Breathing in Sport …, 2023 - books.google.com
OPEN ACCESS EDITED BY Page 114 TYPE Original Research frontiers Frontiers in Physiology
PUBLISHED 21 September 2022 DOI 10.3389/fphys. 2022.949351 Check for updates OPEN …

[PDF][PDF] SEOM-GETNE-TTCC Clinical guideline thyroid cancer (2023)

M Navarro, I Porras, J Hernando, E Maurente Oliveira… - 2024 - scientiasalut.gencat.cat
Thyroid cancer (TC) represents 3% of global cancer incidence. Recent changes have
optimized treatment decisions based on risk assessment, molecular profiling, and imaging …